How much has allogeneic stem cell transplant–related mortality improved since the 1980s? A retrospective analysis from the EBMT

Survival, Nonrelapse Mortality, and Relapse-Related Mortality After Allogeneic Hematopoietic Cell Transplantation: Comparing 2003–2007 Versus 2013–2017 Cohorts

(2020) George B. McDonald et al.   ANNALS OF INTERNAL MEDICINE

The EBMT activity survey on hematopoietic-cell transplantation and cellular therapy 2018: CAR-T’s come into focus

(2020) Jakob R. Passweg et al.   BONE MARROW TRANSPLANTATION

Prophylaxis and management of graft versus host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation

(2020) Olaf Penack et al.   Lancet Haematology

Changes in critically ill cancer patients’ short-term outcome over the last decades: results of systematic review with meta-analysis on individual data

(2019) Michaël Darmon et al.   INTENSIVE CARE MEDICINE

Death after hematopoietic stem cell transplantation: changes over calendar year time, infections and associated factors

(2019) Jan Styczyński et al.   BONE MARROW TRANSPLANTATION

EASIX and mortality after allogeneic stem cell transplantation

(2019) Thomas Luft et al.   BONE MARROW TRANSPLANTATION

Outcomes of allogeneic haematopoietic stem cell transplantation from HLA-matched and alternative donors: a European Society for Blood and Marrow Transplantation registry retrospective analysis

(2019) Roni Shouval et al.   Lancet Haematology

Critically ill allogenic HSCT patients in the intensive care unit: a systematic review and meta-analysis of prognostic factors of mortality

(2018) Colombe Saillard et al.   BONE MARROW TRANSPLANTATION

Trends in patient outcome over the past two decades following allogeneic stem cell transplantation for acute myeloid leukaemia: an ALWP/EBMT analysis

(2018) J. Canaani et al.   JOURNAL OF INTERNAL MEDICINE

Dose-Reduced Versus Standard Conditioning Followed by Allogeneic Stem-Cell Transplantation for Patients With Myelodysplastic Syndrome: A Prospective Randomized Phase III Study of the EBMT (RICMAC Trial)

(2017) Nicolaus Kröger et al.   JOURNAL OF CLINICAL ONCOLOGY

Infections after Transplantation of Bone Marrow or Peripheral Blood Stem Cells from Unrelated Donors

(2016) Jo-Anne H. Young et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Improving results of allogeneic hematopoietic cell transplantation for adults with acute lymphoblastic leukemia in first complete remission: an analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

(2016) Sebastian Giebel et al.   HAEMATOLOGICA

Antilymphocyte Globulin for Prevention of Chronic Graft-versus-Host Disease

(2016) Nicolaus Kröger et al.   NEW ENGLAND JOURNAL OF MEDICINE

Improving results of allogeneic hematopoietic cell transplantation for adults with acute lymphoblastic leukemia in first complete remission: an analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

(2016) Sebastian Giebel et al.   HAEMATOLOGICA

Effectiveness and safety of lower dose prednisone for initial treatment of acute graft-versus-host disease: a randomized controlled trial

(2015) M. Mielcarek et al.   HAEMATOLOGICA

Reduced intensity conditioning allogeneic hematopoietic cell transplantation for adult acute myeloid leukemia in complete remission - a review from the Acute Leukemia Working Party of the EBMT

(2015) S. Sengsayadeth et al.   HAEMATOLOGICA

Effectiveness and safety of lower dose prednisone for initial treatment of acute graft-versus-host disease: a randomized controlled trial

(2015) M. Mielcarek et al.   HAEMATOLOGICA

Reduced intensity conditioning allogeneic hematopoietic cell transplantation for adult acute myeloid leukemia in complete remission - a review from the Acute Leukemia Working Party of the EBMT

(2015) S. Sengsayadeth et al.   HAEMATOLOGICA

Improved Survival after Allogeneic Hematopoietic Stem Cell Transplantation in Recent Years. A Single-Center Study

(2011) Mats Remberger et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

The EBMT risk score

(2011) A Gratwohl   BONE MARROW TRANSPLANTATION

Reducing the Risk for Transplantation-Related Mortality After Allogeneic Hematopoietic Cell Transplantation: How Much Progress Has Been Made?

(2011) John T. Horan et al.   JOURNAL OF CLINICAL ONCOLOGY

Reduced Mortality after Allogeneic Hematopoietic-Cell Transplantation

(2010) Ted A. Gooley et al.   NEW ENGLAND JOURNAL OF MEDICINE

Impacts of Pretransplant Comorbidities on Allogeneic Hematopoietic Cell Transplantation (HCT) Outcomes

(2009) Mohammed Sorror   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Initial therapy of acute graft-versus-host disease with low-dose prednisone does not compromise patient outcomes

(2008) M. Mielcarek et al.   BLOOD